PRO-DEX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
PRO-DEX, INC. (PDEX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $163.10 million as of 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2017-05-11
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $163.10M.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $169.39M.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $169.17M.
- 2016-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $327.68M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2017-03-31 | $163.10M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $169.39M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $169.17M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $327.68M 10-K · filed 2016-09-15 |
| 2016-03-31 | $171.85M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $49.35M 10-Q · filed 2016-02-11 |
| 2015-09-30 | $55.25M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $40.80M 10-K · filed 2015-09-17 |
| 2015-03-31 | $15.30M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $81.72M 10-Q · filed 2015-02-10 |
| 2014-09-30 | $56.72M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $26.92M 10-K · filed 2014-09-18 |
| 2014-03-31 | $13.83M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $67.97K 10-Q · filed 2014-02-06 |
| 2013-09-30 | $14.31K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $6.13K 10-K · filed 2013-09-27 |
| 2013-03-31 | $26.67K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $19.21K 10-Q · filed 2013-02-13 |
| 2012-09-30 | $9.73K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $51.42K 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |